CAMBRIDGE, Mass., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its corporate presentation at two upcoming investor conferences.
Lazard Capital Markets 9th Annual Healthcare Conference
Wednesday, November 14, 2012 at 2:30 p.m. ET in New York, NY
Credit Suisse 2012 Healthcare Conference
Thursday, November 15, 2012 at 10:30 a.m. PT (1:30 p.m. ET) in Phoenix, AZ
The audio webcast of the presentations will be available live on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentations will be posted on the Momenta website approximately one hour after the event and will be available for two weeks following the presentation.
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Lora Pike Momenta Pharmaceuticals, Inc. 617.395.5189